1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 186 F.Supp.3d
  5. 186 F.Supp.3d 22 (2016)
 

DANA-FARBER CANCER INSTITUTE v. ONO PHARMACEUTICAL

C.A. No. 15-13443-MLW.

186 F.Supp.3d 22 (2016)

DANA-FARBER CANCER INSTITUTE, INC., Plaintiff, v. ONO PHARMACEUTICAL CO., LTD., Tasuku Honjo, E.R. Squibb & Sons, L.L.C., and Bristol-Myers Squibb, Co., Defendants.

United States District Court, D. Massachusetts.

Signed May 2, 2016.

Attorney(s) appearing for the Case

Donald R. Ware , Barbara A. Fiacco , Michael B. Hoven , Sarah S. Burg , Foley Hoag LLP, Boston, MA, for Plaintiff.

Dianne B. Elderkin , Jason Weil , Matthew A. Pearson , Melissa R. Gibson , Steven D. Maslowski , Akin Gump Strauss Hauer & Feld LLP, Philadelphia, PA, Amy K. Wigmore , Wilmer Cutler Pickering Hale and Dorr LLP, Rachel J. Elsby , Emily C. Johnson , Akin Gump Strauss Hauer & Feld, LLP, Washington, DC, Kelli J. Powell , Kevin S. Prussia , Wilmer Cutler Pickering Hale and Dorr LLP, Boston, MA, for Defendants.

MEMORANDUM AND ORDER

In this case, plaintiff Dana-Farber Cancer Institute, Inc. ("Dana-Farber") seeks to correct inventorship of five patents. Defendants Ono Pharmaceuticals, Ltd. ("Ono"), Tasuku Honjo ("Honjo"), and E.R. Squibb & Sons, L.L.C. and Bristol-Myers Squibb, Co. (collectively "BMS") have moved to transfer...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases